Introduction

Internal Update 2012

The Pearls

March 3, 2012
Victoria Conference Centre
Victoria, British Columbia

For all interested Health Care Providers.

CME Credits

This program has been accredited by The College of Family Physicians of Canada and the British Columbia Chapter for up to 6 Mainpro-M1 credits.

This event is an Accredited Group Learning Activity eligible for up to 6.0 Section 1 credits as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada. This program as been reviewed and approved by the UBC Division of Continuing Professional Development.

Introduction

We are pleased to present our ninth annual Internal Medicine Update conference. We will be covering many hot and clinically relevant topics which you face every day in your practice both in hospital and office.

Topics will be presented in didactic as well as small group sessions to allow one on one interaction. We have brought together speakers who are known for their teaching and presentaion skills to make this both a productive and interesting day. Topics will be clinically orientated, and you will be brought to date on the most current developments in a wide number of areas of Internal Medicine.

Objectives:

At the end of this conference participants will be able to:

  • list options and indications for coronary artery disease imaging including MIBI, CT and MRI.
  • describe new tests & new drugs in the management of Rheumatoid Arthritis.
  • diagnose and describe at least three of these five conditions: neurological work-up of a dizzy patient, acute inflammatory arthropathy, medications for type 2 Diabetes, causes & bedside assessment of weakness and assessment of non-acute coronary artery disease.
  • discuss the top ten apps in health care.
  • describe new oral anticoagulants and /or Warfarin for stroke prevention and also hypertension and the incidental adrenal mass.
  • discuss the management of chronic liver disease and the dermatologic manifestations of systemic diseases.